8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 8 of 8 clinical reviews.
Drake publicly confirmed using Ozempic in 2023, becoming one of the first major male celebrities to openly discuss GLP-1 medication. The HealthRX.com Medical Team breaks down the clinical context behind his disclosure.
Drake publicly confirmed Ozempic use in 2023, making him one of the first male celebrities to openly discuss GLP-1 therapy. Here the HealthRX.com Medical Team compares his disclosure to other public figures and layers rigorous clinical context on what these drugs actually do.
A clinical timeline of Drake's confirmed Ozempic use, documented body composition changes from 2022 to 2024, and the GLP-1 pharmacology behind each phase.
Drake confirmed Ozempic use in 2023. The HealthRX.com Medical Team breaks down what clinical research says about GLP-1 discontinuation, weight regain, and long-term maintenance strategies.
Drake confirmed Ozempic use in 2023. The HealthRX.com Medical Team maps the side effects he has publicly referenced against the FDA label and peer-reviewed GLP-1 receptor agonist trial data.
Drake publicly confirmed Ozempic use in 2023, making him one of the first male celebrities to do so openly. Here is what the HealthRX.com Medical Team says non-celebrity patients can actually learn from his public story about GLP-1 expectations, side effects, and discontinuation.
Drake confirmed Ozempic use in 2023. The HealthRX.com Medical Team breaks down what his GLP-1 regimen would actually cost a non-celebrity patient navigating insurance, pharmacy tiers, and prior authorization.
Drake confirmed Ozempic use in 2023. The HealthRX.com Medical Team breaks down what a real semaglutide prescribing protocol looks like for a male patient with his publicly documented profile.